

Material Number:
NAT-00863
Active Ingredient:
Erlotinib hydrochloride tablets
Bioequivalent to*:
Tarceva®
Therapeutic Class (AHFS):
Epidermal Growth Factor Receptor (EGFR)
Tyrosine Kinase Inhibitor
Tyrosine Kinase Inhibitor
Strength:
100 MG
DIN:
02483920
UPC:
7540173000863
Pack Size (Form):
30 Tablets (Bottle)
Dosage Form:
Tablets
Scored:
N/A
Colour:
White
Shape:
Round, biconvex
Markings:
Film-coated tablets debossed with “N 100” on one side and plain on other side.
Route of Administration:
Oral
Refrigeration Required:
No
Product Resources:
Packaging Information:
Height | Width | Length | Weight | Unit/Case | |
---|---|---|---|---|---|
Unit | 65 mm | 38 mm | 38 mm | 0.0253 Kg | N/A |
Inner | 85 mm | 120 mm | 158 mm | 0.6036 Kg | 12 units/Inner |
Case | 190 mm | 325 mm | 380 mm | 8.0 Kg | 144 units/case |
Provincial Formulary Legend:
B
Benefit (Non-Interchangeable)
BNL
Brand Not Listed
I
Interchangeable
O
Other
SAR
Submission Awaiting Review
X
Interchangeable Benefit
*All other brand or product names located in this site are Trademarks of their respective holders.